Advancements in understanding and treating psoriasis: a comprehensive review of pathophysiology, diagnosis, and therapeutic approaches
Open Access
Abstract
Psoriasis is a chronic autoimmune disease affecting millions worldwide. This condition is characterized by scaly, red patches of skin that can be painful, itchy, and disfiguring. This non-contagious illness forms plaques and accelerates the dermal cell’s life cycle. This review provides a comprehensive overview of the current knowledge on psoriasis, covering its definition, prevalence, causes, pathogenesis, clinical features, diagnosis, and treatment options. The psychosocial impact of psoriasis on patients and their coping mechanisms is also explored. Biologic agents, which target specific cytokines involved in psoriasis pathogenesis, have revolutionized psoriasis treatment and have significantly improved patient outcomes. However, effective and safe treatments for moderate to severe psoriasis are still needed. Future research directions include the development of biomarkers for predicting disease severity and treatment response, investigating new therapeutic targets like the microbiome and epigenetics, and leveraging advancements in technology and genomics for deeper insights into psoriasis pathogenesis and treatment. This study summarizes the key aspects of psoriasis, including its epidemiology, pathophysiology, clinical traits, disease burden, and management. However, further research is needed to improve treatment outcomes and enhance the quality of life for patients affected by this complex condition.Keywords
Funding Information
- Indian Council for Medical Research
This publication has 83 references indexed in Scilit:
- Real-World Biologic Adherence, Persistence, and Monotherapy Comparisons in US Patients with Psoriasis: Results from IBM MarketScan® DatabasesAdvances in Therapy, 2022
- Psoriasis and Cardiovascular Disease: Novel Mechanisms and Evolving TherapeuticsCurrent Atherosclerosis Reports, 2021
- Psoriasis Prevalence in Adults in the United StatesJAMA Dermatology, 2021
- Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus RecommendationsDermatology and Therapy, 2021
- Pathophysiology, Clinical Presentation, and Treatment of PsoriasisJAMA, 2020
- Psoriasis and the metabolic syndromeClinics in Dermatology, 2018
- US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) SurveyAmerican Journal of Clinical Dermatology, 2015
- Cytokines in psoriasisCytokine, 2015
- Systemic Therapies for Psoriasis: An Evidence-Based UpdateAmerican Journal of Clinical Dermatology, 2014
- PSORS2 Is Due to Mutations in CARD14The American Journal of Human Genetics, 2012